Kevin Lawson
Vorstandsvorsitzender bei KSL Biomedical, Inc.
Profil
Kevin Lawson has held positions as Chief Executive Officer & Partner at KSL Biomedical, Inc. and Director at Southwest Behavioral Health Services, Inc.
Aktive Positionen von Kevin Lawson
Unternehmen | Position | Beginn |
---|---|---|
Southwest Behavioral Health Services, Inc.
Southwest Behavioral Health Services, Inc. Medical/Nursing ServicesHealth Services Southwest Behavioral Health Services, Inc. provides individualized and professional emotional and mental healthcare services. Its range of services include adult outpatient clinics, adolescent/children outpatient services, residential programs, in-home services, substance abuse programs, homeless outreach, prevention programs, and crisis recovery services. The company was founded in 1969 and is headquartered in Phoenix, AZ. | Direktor/Vorstandsmitglied | - |
KSL Biomedical, Inc.
KSL Biomedical, Inc. Packaged SoftwareTechnology Services KSL Biomedical, Inc. is a translational medicine technology company that provides diagnostic and therapeutic intellectual property for immunology, oncology, and genomics. The private company is based in Buffalo, NY and has subsidiaries in Canada. The company offers proprietary diagnostic services, technology and regulatory consulting services, and international regulatory clearance and licensing. KSL has professionals with many decades of experience in international regulatory compliance, product design and development, clinical trials, and protection of intellectual property to work with healthcare industry partners to address their need for special resources to achieve and maintain compliance. The company has integrated clinical laboratories that are readily accessible for product clinical evaluation and clinical studies, including pre-clinical and clinical study testing and support, clinical study or evaluation reports, post-market studies, medical advisor review, and risk consulting. KSL's CRO team has decades of scientific, medical, and regulatory writing experience for a wide variety of documents. The company has managed approval of thousands of products through FDA listing, FDA premarket notification (510 (k)) clearance, premarket approval (PMA) approval, Health Canada licensing, state department of health validations, and more. The regulatory expertise of the KSL CRO business unit in conjunction with the clinical laboratory foundation of KSL diagnostics offers a powerful model to rapidly develop and deploy novel diagnostics. The CEO of the company is Kevin Lawson. | Vorstandsvorsitzender | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Southwest Behavioral Health Services, Inc.
Southwest Behavioral Health Services, Inc. Medical/Nursing ServicesHealth Services Southwest Behavioral Health Services, Inc. provides individualized and professional emotional and mental healthcare services. Its range of services include adult outpatient clinics, adolescent/children outpatient services, residential programs, in-home services, substance abuse programs, homeless outreach, prevention programs, and crisis recovery services. The company was founded in 1969 and is headquartered in Phoenix, AZ. | Health Services |
KSL Biomedical, Inc.
KSL Biomedical, Inc. Packaged SoftwareTechnology Services KSL Biomedical, Inc. is a translational medicine technology company that provides diagnostic and therapeutic intellectual property for immunology, oncology, and genomics. The private company is based in Buffalo, NY and has subsidiaries in Canada. The company offers proprietary diagnostic services, technology and regulatory consulting services, and international regulatory clearance and licensing. KSL has professionals with many decades of experience in international regulatory compliance, product design and development, clinical trials, and protection of intellectual property to work with healthcare industry partners to address their need for special resources to achieve and maintain compliance. The company has integrated clinical laboratories that are readily accessible for product clinical evaluation and clinical studies, including pre-clinical and clinical study testing and support, clinical study or evaluation reports, post-market studies, medical advisor review, and risk consulting. KSL's CRO team has decades of scientific, medical, and regulatory writing experience for a wide variety of documents. The company has managed approval of thousands of products through FDA listing, FDA premarket notification (510 (k)) clearance, premarket approval (PMA) approval, Health Canada licensing, state department of health validations, and more. The regulatory expertise of the KSL CRO business unit in conjunction with the clinical laboratory foundation of KSL diagnostics offers a powerful model to rapidly develop and deploy novel diagnostics. The CEO of the company is Kevin Lawson. | Technology Services |